Medical cannabis in the UK: From principle to practice
Blog
At Drug Science we like to cover different topics relating to drugs. These topics cover the many different ways that psychoactive substances have an impact on our culture and society.
- Apr 28, 2020
- 4 min
When we waken from the COVID nightmare – what then?
- Jan 30, 2020
- 2 min
Reported effects of psychedelic use on those with low well-being given various emotional states and social contexts
- Sep 3, 2019
- 1 min
2018: A watershed year for psychedelic science
- Aug 27, 2019
- 2 min
NICE on cannabidiol for childhood epilepsy
- Jul 22, 2019
- 2 min
First safety study of MDMA-assisted psychotherapy in patients with alcohol use disorder
- May 16, 2019
- 3 min
Drug Science launches Working Group on Medical Cannabis
- Sep 11, 2018
- 2 min
ACMD advice on cannabis-derived medicinal products
- Apr 11, 2018
- 1 min
The early use of MDMA (‘Ecstasy’) in psychotherapy (1977–1985)
- Jul 26, 2017
- 1 min
Psychedelic drug use in healthy individuals: A review of benefits, costs, and implications for drug policy
- Dec 10, 2016
- 4 min
Psilocybin for anxiety and depression in cancer care? Lessons from the past and prospects for the future
- Apr 3, 2016
- 3 min
Cannabis Review for the attention of the WHO
- Mar 3, 2016
- 1 min
Ketamine as an essential medicine
- Mar 24, 2015
- 1 min
Underground MDMA-, LSD- and 2-CB-assisted individual and group psychotherapy in Zurich: Outcomes, implications and commentary
- Feb 10, 2015
- 3 min
The UK needs common sense about ketamine